首页> 美国卫生研究院文献>Internal Medicine >Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion
【2h】

Cardiac Tamponade as a Recurrence of Angioimmunoblastic T-Cell Lymphoma with the Detection of a p.Gly17Val RHOA Mutation in the Pericardial Effusion

机译:心包填塞作为血管免疫母细胞性 T 细胞淋巴瘤的复发在心包积液中检测到 p.Gly17Val RHOA 突变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Angioimmunoblastic T-cell lymphoma (AITL) is an intractable type of T-cell lymphoma. We and others have identified that the p.Gly17Val RHOA mutation is specifically identified in AITL. We herein report a patient whose condition deteriorated, resulting from massive pericardial effusion one month after undergoing autologous transplantation for AITL. He was diagnosed with cardiac tamponade caused by AITL recurrence in the presence of the p.Gly17Val RHOA mutation as well as T-lineage cells with an aberrant immune-phenotype in the pericardial effusion. This case suggests that a precision medicine approach by detecting the presence of a p.Gly17Val RHOA mutation is useful for the management of AITL.
机译:血管免疫母细胞性 T 细胞淋巴瘤 (AITL) 是一种顽固性 T 细胞淋巴瘤。我们和其他人已经确定 p.Gly17Val RHOA 突变在 AITL 中被特异性识别。我们在此报告一名患者,其病情恶化,原因是在接受 AITL 自体移植 1 个月后出现大量心包积液。他被诊断为心脏填塞,这是在存在 p.Gly17Val RHOA 突变的情况下由 AITL 复发引起的,以及心包积液中免疫表型异常的 T 系细胞。本病例表明,通过检测 p.Gly17Val RHOA 突变的精准医学方法对 AITL 的管理很有用。

著录项

代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号